Latest in Novo Nordisk
Sort by
16 items
-
With Novo Nordisk success, is there a "Nokia risk" for Denmark?
Correspondent Jon Wertheim revisits 60 Minutes' coverage of former mobile giant Nokia and discusses potential risks for the Danish economy.Top stories - CBS News - November 3 -
Novo Nordisk's Wegovy Sales Beat Expectations
The pharmaceutical giant’s blockbuster weight-loss drug beat sales expectations in the third quarter, sending shares higher in early trade.Business - The Wall Street Journal - November 6 -
The Novo Nordisk scientist behind Ozempic, Wegovy weight loss research
Drugs Ozempic and Wegovy have slimmed down Hollywood stars — and millions of non-celebrities worldwide — while adding great heft to the economy of Novo Nordisk’s home country, Denmark.Top stories - CBS News - November 4 -
Novo Nordisk's obesity-fighting drugs fatten Denmark's economy
Danish company Novo Nordisk has a market cap larger than the entire country's GDP. As it grows, it's having an impact on other industries.Top stories - CBS News - November 3 -
Weight loss drug industry injects wealth into Novo Nordisk home country
Drugs Ozempic and Wegovy have slimmed down Hollywood stars — and millions of non-celebrities worldwide— while adding great heft to the economy of Novo Nordisk's home country, Denmark.Top stories - CBS News - November 3 -
Novo Nordisk shares jump 8% after Wegovy sales beat expectations
Novo Nordisk on Wednesday reported third quarter earnings broadly in line with expectations and narrowed its 2024 full-year growth guidance.Business - CNBC - November 6 -
Ozempic maker Novo Nordisk nudges higher profit forecast
Novo Nordisk on Wednesday nudged higher its outlook for the year as the drugmaker registered another quarter of strong sales of its weight-loss drugs.Business - MarketWatch - November 6 -
Novo Nordisk Launches Wegovy Weight-Loss Drug in China
The first prescription for the drug in China will reportedly be issued at a public hospital in Shanghai this week and will cost about $193 for a one-month supply of the lowest starter dose.Business - The Wall Street Journal - 2 days ago -
Novo Nordisk asks FDA to ban compounding pharmacies from making Ozempic, Wegovy copies
The Danish drugmaker Novo Nordisk argues that semaglutide, the active ingredient in Ozempic and Wegovy, are too complex for those manufacturers to make safely.Business - CNBC - October 23 -
Novo Nordisk asks FDA to block compounding pharmacies from making Ozempic copycats
Novo Nordisk wants the Food and Drug Administration (FDA) to prevent compounding pharmacies from manufacturing their own versions of the company’s popular weight loss drug Wegovy and diabetes ...Politics - The Hill - October 23 -
Novo Nordisk's diabetes drug Ozempic may reduce the risk of Alzheimer's disease, study says
The active ingredient in Ozempic was associated with a 40% to 70% lower risk of a first-time Alzheimer's diagnosis in diabetes patients.Business - CNBC - October 24 -
Novo Nordisk's Ozempic and Wegovy now available in the U.S. after shortages, FDA says
It is a sign that Novo Nordisk's efforts to ramp up the supply of those drugs are starting to pay off, as demand continues to skyrocket in the U.S.Business - CNBC - October 30 -
The Land Of Novo I Sunday on 60 Minutes
Denmark—home to some of the world's wealthiest and healthiest people—is now home to Europe's largest company, Novo Nordisk. The company's weight loss wonder drugs Ozempic and Wegovy have slimmed ...Top stories - CBS News - October 31 -
11/03/2024: Election Truth; Unintended Consequences; The Land of Novo
First, how Georgia election officials fight voting misinformation. Then, a look at the consequences of Texas' strict abortion laws. And, meet the Novo Nordisk scientist behind Ozempic, Wegovy.Top stories - CBS News - November 3
